The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Detecting masked high blood pressure in high-risk patients

  • Kim, Hyungseop (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center)
  • Received : 2015.07.20
  • Accepted : 2015.07.24
  • Published : 2015.09.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
  2. de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011;57:898-902. https://doi.org/10.1161/HYPERTENSIONAHA.110.168948
  3. Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359-1366. https://doi.org/10.1097/HJH.0000000000000221
  4. Conen D, Aeschbacher S, Thijs L, et al. Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension 2014;64:1073-1079. https://doi.org/10.1161/HYPERTENSIONAHA.114.03957
  5. Shin J, Park SH, Kim JH, et al. Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group. Korean J Intern Med 2015;30:610-619. https://doi.org/10.3904/kjim.2015.30.5.610
  6. Stergiou GS, Asayama K, Thijs L, et al. Prognosis of whitecoat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2014;63:675-682. https://doi.org/10.1161/HYPERTENSIONAHA.113.02741
  7. Lehmann MV, Zeymer U, Dechend R, et al. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study. Int J Cardiol 2013;168:2255-2263. https://doi.org/10.1016/j.ijcard.2013.01.209
  8. Balta S, Demirkol S, Celik T, Unlu M, Kucuk U, Arslan Z. Inflammatory markers should be assessed together with cardiovascular risk factors by clinicians in masked hypertension. J Clin Hypertens (Greenwich) 2013;15:443-444. https://doi.org/10.1111/jch.12120
  9. Hara A, Ohkubo T, Kikuya M, et al. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens 2007;25:321-327. https://doi.org/10.1097/HJH.0b013e3280115bbf
  10. Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 2014;35:3304-3312. https://doi.org/10.1093/eurheartj/ehu016